Latest Breaking News On - Rx business development - Page 1 : comparemela.com

Liquidia Corporation Announces Chief Executive Officer Transition Liquidia Corporation Announces Chief Executive Officer Transition RESEARCH TRIANGLE PARK, N.C., Dec. 14, 2020 Liquidia Corporation (NASDAQ: LQDA) today announced Damian deGoa has been appointed as Chief Executive Officer (CEO) and a director of the Company, effective immediately. He succeeds Neal F. Fowler who has retired as CEO and a director of the Company. Mr. Fowler has agreed to provide assistance to the Company for a short period of time to support a smooth transition. “Damian is a strategic and proven leader in the healthcare industry, having led several companies in various stages of operations, most notably as Chief Executive Officer of RareGen from its formation in Summer 2018 through its acquisition by Liquidia in November 2020,” said Dr. Stephen Bloch, Chairman of the Company’s Board of Directors. “We are thrilled to welcome Damian’s wealth of experience in the pulmonary arterial hypertensio

United statesNealf fowlerStephen blochSeth rudnickFosun pharmaLiquidia technologies incUs district courtHead of international business developmentUniversity of michiganTrademark officeMichael parks corporate communicationsResearch triangle parkDepaul universityCompany board of directorsSandoz incLiquidia corporation